I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 25% ± 6% | |
| dendritic cell | 3 studies | 26% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 25% ± 6% | |
| dendritic cell | 3 studies | 26% ± 5% |
Insufficient scRNA-seq data for expression of SLC35A4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 5393.07 | 1445 / 1445 | 100% | 109.20 | 183 / 183 |
| liver | 100% | 3512.81 | 226 / 226 | 100% | 64.03 | 406 / 406 |
| ovary | 100% | 3630.66 | 180 / 180 | 100% | 105.82 | 430 / 430 |
| skin | 100% | 6316.21 | 1809 / 1809 | 100% | 125.66 | 472 / 472 |
| thymus | 100% | 5850.25 | 653 / 653 | 100% | 84.22 | 605 / 605 |
| uterus | 100% | 4011.82 | 170 / 170 | 100% | 88.71 | 459 / 459 |
| kidney | 100% | 6462.18 | 89 / 89 | 100% | 109.78 | 899 / 901 |
| pancreas | 100% | 2774.19 | 327 / 328 | 100% | 75.34 | 178 / 178 |
| intestine | 100% | 5063.45 | 966 / 966 | 100% | 91.49 | 525 / 527 |
| prostate | 100% | 5399.98 | 245 / 245 | 100% | 108.94 | 500 / 502 |
| adrenal gland | 100% | 7091.03 | 258 / 258 | 100% | 79.33 | 229 / 230 |
| brain | 99% | 2568.26 | 2627 / 2642 | 100% | 86.94 | 705 / 705 |
| lung | 100% | 5733.59 | 578 / 578 | 99% | 76.42 | 1147 / 1155 |
| stomach | 100% | 4408.97 | 359 / 359 | 99% | 90.68 | 284 / 286 |
| breast | 100% | 5242.80 | 459 / 459 | 99% | 104.00 | 1108 / 1118 |
| bladder | 100% | 4376.43 | 21 / 21 | 99% | 79.51 | 498 / 504 |
| adipose | 100% | 5308.39 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 123.35 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 110.83 | 29 / 29 |
| muscle | 100% | 8722.44 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 5805.73 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 99.96 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 41.98 | 1 / 1 |
| blood vessel | 100% | 3974.15 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 100% | 4809.93 | 859 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 96% | 4229.45 | 890 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0090481 | Biological process | pyrimidine nucleotide-sugar transmembrane transport |
| GO_0032056 | Biological process | positive regulation of translation in response to stress |
| GO_0055085 | Biological process | transmembrane transport |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0016020 | Cellular component | membrane |
| GO_0015165 | Molecular function | pyrimidine nucleotide-sugar transmembrane transporter activity |
| GO_0022857 | Molecular function | transmembrane transporter activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SLC35A4 |
| Protein name | Probable UDP-sugar transporter protein SLC35A4 (Solute carrier family 35 member A4) SLC35A4 upstream open reading frame protein |
| Synonyms | |
| Description | FUNCTION: Mediates the transport of CDP-ribitol . Does not exhibit CMP-sialic acid, UDP-galactose and UDP-N-acetylglucosamine transport activity . . |
| Accessions | ENST00000323146.8 [Q96G79-1] Q96G79 ENST00000612662.2 [Q96G79-1] ENST00000514199.1 [Q96G79-1] ENST00000623481.3 [L0R6Q1-1] L0R6Q1 |
